Cargando…
Antitumor effector B cells directly kill tumor cells involving the CXCL12/CXCR4 pathway and their therapeutic efficacy is enhanced by IL-2
Autores principales: | Li, Qiao, Xia, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645256/ http://dx.doi.org/10.1186/2051-1426-3-S2-P27 |
Ejemplares similares
-
IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways
por: Xia, Yang, et al.
Publicado: (2016) -
The expression of CXCR4/CXCL12 determines subsets of patients in systemic lupus erythematosus
por: Guilpain, Philippe, et al.
Publicado: (2011) -
Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
por: Werner, Lael, et al.
Publicado: (2013) -
IL-12 priming during initial antigen contact increases generation of effector and memory CD8 T cells by changing properties
por: Chang, J, et al.
Publicado: (2003) -
Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)